Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G, Moshkelgosha S, Köhling HL, Covelli D, Banga JP, Berchner-Pfannschmidt U, Horstmann M, Diaz-Cano S, Goertz GE, Plummer S, Eckstein A, Ludgate M, Biscarini F, Marchesi JR; INDIGO consortium. Masetti G, et al. Among authors: eckstein a. Microbiome. 2018 May 25;6(1):97. doi: 10.1186/s40168-018-0478-4. Microbiome. 2018. PMID: 29801507 Free PMC article.
A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbit.
Meyer zu Hörste M, Ströher E, Berchner-Pfannschmidt U, Schmitz-Spanke S, Pink M, Göthert JR, Fischer JW, Gulbins E, Eckstein AK. Meyer zu Hörste M, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):E1727-36. doi: 10.1210/jc.2011-1156. Epub 2011 Sep 14. J Clin Endocrinol Metab. 2011. PMID: 21917865
[Update on endocrine orbitopathy].
Eckstein A, Berchner-Pfannschmidt U, Führer D, Esser J. Eckstein A, et al. Ophthalmologe. 2013 Nov;110(11):1079-96. doi: 10.1007/s00347-013-2976-x. Ophthalmologe. 2013. PMID: 24231915 German.
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
Perros P, Žarković M, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi A, Bournaud C, Brix TH, Covelli D, Ćirić S, Daumerie C, Eckstein A, Fichter N, Führer D, Hegedüs L, Kahaly GJ, Konuk O, Lareida J, Lazarus J, Leo M, Mathiopoulou L, Menconi F, Morris D, Okosieme O, Orgiazzi J, Pitz S, Salvi M, Vardanian-Vartin C, Wiersinga W, Bernard M, Clarke L, Currò N, Dayan C, Dickinson J, Knežević M, Lane C, Marcocci C, Marinò M, Möller L, Nardi M, Neoh C, Pearce S, von Arx G, Törüner FB. Perros P, et al. Among authors: eckstein a. Br J Ophthalmol. 2015 Nov;99(11):1531-5. doi: 10.1136/bjophthalmol-2015-306733. Epub 2015 May 7. Br J Ophthalmol. 2015. PMID: 25953846
Modeling Graves' Orbitopathy in Experimental Graves' Disease.
Banga JP, Moshkelgosha S, Berchner-Pfannschmidt U, Eckstein A. Banga JP, et al. Among authors: eckstein a. Horm Metab Res. 2015 Sep;47(10):797-803. doi: 10.1055/s-0035-1555956. Epub 2015 Aug 19. Horm Metab Res. 2015. PMID: 26287396 Review.
224 results